K Kurose, E Sugiyama, Y Saito - Drug metabolism and …, 2012 - jstage.jst.go.jp
Drug lag, recently discussed extensively in Japan, can be divided into two phases: clinical development time and application review time. The former factor is still an important problem …
F Meric-Bernstam, L Brusco, M Daniels, C Wathoo… - Annals of …, 2016 - Elsevier
Background Next-generation sequencing in cancer research may reveal germline variants of clinical significance. We report patient preferences for return of results and the prevalence …
M Panczyk - World Journal of Gastroenterology: WJG, 2014 - ncbi.nlm.nih.gov
During the past two decades the first sequencing of the human genome was performed showing its high degree of inter-individual differentiation, as a result of large international …
K Sai, M Saeki, Y Saito, S Ozawa… - Clinical …, 2004 - Wiley Online Library
Purpose A comprehensive haplotype analysis of UGT1A1 in the Japanese population was conducted, and the effects of these haplotypes were investigated with respect to UGT1A1 …
The anticancer agent irinotecan (CPT-11) is converted to SN-38, which is approximately 100 to 1000-fold more cytotoxic than the parent drug. The pharmacokinetics of irinotecan are …
The uridine diphosphoglucuronosyltransferases (UGTs) belong to a superfamily of enzymes that catalyse the glucuronidation of numerous endobiotics and xenobiotics. Several human …
Abstract Irinotecan (CPT-11), a first-line chemotherapy for advanced colorectal cancer, causes serious diarrhea in patients receiving treatment. The underlying mechanism has …
AA Albassam, JS Markowitz - Planta medica, 2017 - thieme-connect.com
This review summarizes published in vitro, animal, and clinical studies investigating the effects of green tea (Camellia sinensis) extract and associated catechins on drug …
BACKGROUND FOLFIRINOX and gemcitabine plus nab-paclitaxel (Gem+ nabPTX) were recently introduced for metastatic pancreatic cancer treatment. However, studies that …